Stockscreener 앱 받기
17.65
0.80%
0.1259
전일 마감가:
$17.52
열려 있는:
$17.19
하루 거래량:
308.76K
Relative Volume:
0.36
시가총액:
$1.90B
수익:
$577.74M
순이익/손실:
$-149.78M
주가수익비율:
-12.60
EPS:
-1.4
순현금흐름:
$-78.21M
1주 성능:
-4.23%
1개월 성능:
-7.39%
6개월 성능:
+13.94%
1년 성능:
+22.72%
1일 변동 폭
$17.18
$17.88
1주일 범위
$17.18
$19.06
52주 변동 폭
$11.70
$34.13
Novocure Ltd Stock (NVCR) Company Profile
명칭
Novocure Ltd
전화
44 (0)15 3475 6700
주소
NO. 4 THE FORUM, ST. HELIER
NVCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVCR
Novocure Ltd
|
17.65 | 1.90B | 577.74M | -149.78M | -78.21M | -1.40 |
|
ABT
Abbott Laboratories
|
131.48 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.19 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.56 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.69 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-10-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-08-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-08-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | 개시 | SVB Securities | Outperform |
| 2023-07-31 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2023-06-07 | 업그레이드 | Wedbush | Underperform → Neutral |
| 2023-05-16 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-17 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-01-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-05 | 재확인 | H.C. Wainwright | Buy |
| 2022-11-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-24 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-07-05 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2022-05-16 | 개시 | H.C. Wainwright | Buy |
| 2022-02-08 | 개시 | Loop Capital | Buy |
| 2022-02-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-20 | 업그레이드 | Truist | Hold → Buy |
| 2022-01-03 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-07-01 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2021-01-25 | 재확인 | Piper Sandler | Overweight |
| 2020-09-23 | 개시 | Northland Capital | Outperform |
| 2020-09-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-09-17 | 다운그레이드 | Truist | Buy → Hold |
| 2020-06-01 | 재개 | Oppenheimer | Perform |
| 2020-05-01 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-03-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-07-29 | 업그레이드 | SunTrust | Hold → Buy |
| 2019-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2018-11-02 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2018-07-16 | 개시 | Evercore ISI | Outperform |
| 2018-04-18 | 재확인 | Mizuho | Buy |
| 2018-02-23 | 재확인 | Mizuho | Buy |
| 2017-05-24 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-07-29 | 재확인 | Wedbush | Outperform |
| 2016-01-19 | 개시 | Barclays | Underweight |
| 2015-12-02 | 개시 | Deutsche Bank | Hold |
모두보기
Novocure Ltd 주식(NVCR)의 최신 뉴스
Novocure to Report First Quarter 2025 Financial Results - Yahoo Finance
Emerald Advisers LLC Takes Position in NovoCure Limited (NASDAQ:NVCR) - MarketBeat
Proficio Capital Partners LLC Acquires Shares of 30,158 NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of “Moderate Buy” from Analysts - The AM Reporter
NovoCure Beats Investor Lawsuit Over Cancer Trial Data Results - Bloomberg Law News
Charles Schwab Investment Management Inc. Has $24.92 Million Stake in NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure Beats Investor Suit Over Cancer Therapy Trial Data (1) - Bloomberg Law News
NovoCure (NASDAQ:NVCR) Rating Increased to Hold at StockNews.com - Defense World
Bank of New York Mellon Corp Increases Stock Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
An Analysis of NovoCure Ltd (NVCR)’s Potential Price Growth - Knox Daily
Novocure at Leerink’s Global Healthcare Conference: Expanding TTFields - Investing.com India
Novocure at Leerink’s Global Healthcare Conference: Expanding TTFields By Investing.com - Investing.com UK
Principal Financial Group Inc. Invests $272,000 in NovoCure Limited (NASDAQ:NVCR) - Defense World
Novocure Ltd. to Host Earnings Call - ACCESS Newswire
Truist Financial Corp Invests $340,000 in NovoCure Limited (NASDAQ:NVCR) - Defense World
Don't Ignore The Insider Selling In NovoCure - Simply Wall St
Novocure’s EVP sells shares worth $46,841 By Investing.com - Investing.com Australia
Insider Sell Alert: Frank Leonard Sells 15,036 Shares of NovoCure Ltd (NVCR) - GuruFocus.com
Prediction: Novocure (NVCR) Will Beat the Market. Here's Why - MSN
Novocure’s chief innovation officer sells shares worth $5,071 - Investing.com India
Novocure’s EVP sells shares worth $46,841 - Investing.com India
Novocure CEO Ashley Cordova sells shares valued at $38,055 By Investing.com - Investing.com South Africa
Novocure CEO Ashley Cordova sells shares valued at $38,055 - Investing.com
Novocure COO sells shares worth $4,634 By Investing.com - Investing.com Australia
Novocure COO sells shares worth $4,634 - Investing.com
Novocure’s COO Paravasthu Mukund sells shares worth $39,687 By Investing.com - Investing.com Australia
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference - Yahoo Finance
NovoCure (NASDAQ:NVCR) Lowered to “Sell” Rating by StockNews.com - Defense World
NovoCure Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Insider Sell: Uri Weinberg Sells Shares of NovoCure Ltd (NVCR) - GuruFocus.com
NovoCure’s Earnings Call: Growth Amid Challenges - MSN
Novocure executive sells shares for $296,256 By Investing.com - Investing.com South Africa
Novocure’s COO Paravasthu Mukund sells shares worth $39,687 - Investing.com India
Novocure CEO Ashley Cordova disposes shares worth $266,126 - Investing.com India
Novocure CEO Ashley Cordova disposes shares worth $266,126 By Investing.com - Investing.com Canada
Q1 Earnings Estimate for NovoCure Issued By Leerink Partnrs - Defense World
New York State Common Retirement Fund Increases Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
New York State Common Retirement Fund Grows Stake in NovoCure Limited (NASDAQ:NVCR) - Armenian Reporter
Some Confidence Is Lacking In NovoCure Limited (NASDAQ:NVCR) As Shares Slide 25% - Simply Wall St
Los Angeles Capital Management LLC Acquires 55,334 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
Rhumbline Advisers Buys 3,115 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure (NASDAQ:NVCR) Posts Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus.com
Commit To Buy NovoCure At $13, Earn 22.3% Using Options - Nasdaq
NovoCure (NASDAQ:NVCR) Shares Gap Down After Earnings Miss - MarketBeat
NovoCure Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... - Yahoo Finance
Novocure Reports Strong 2024 Revenue Growth - TipRanks
NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025 - Benzinga
Novocure reports Q4 EPS (61c), consensus (34c) - TipRanks
Novocure shares fall as Q4 earnings miss overshadows revenue beat By Investing.com - Investing.com South Africa
Novocure Ltd (NVCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Novocure Ltd 주식 (NVCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Leonard Frank X | EVP, Pres., Novocure Oncology |
Mar 03 '25 |
Sale |
18.54 |
2,527 |
46,841 |
143,673 |
| Cordova Ashley | Chief Executive Officer |
Mar 03 '25 |
Sale |
18.54 |
2,053 |
38,055 |
204,005 |
| Paravasthu Mukund | Chief Operating Officer |
Mar 03 '25 |
Sale |
18.54 |
250 |
4,634 |
29,173 |
0.69%
0.15%
자본화:
|
볼륨(24시간):